Pituitary Apoplexy: Comorbidities, Management, and Outcomes—A Spanish Observational Multicenter Study
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae649 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Betina Biagetti und 32 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology & Nutrition Department, Hospital Universitario Vall de Hebrón, CIBERER U747 (ISCIII), ENDO-ERN, Universitat Autónoma de Bracelona, Barc…. Hauptthemen laut MEDLINE: Pituitary Apoplexy, Pituitary Neoplasms, Adenoma, Conservative Treatment. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
Pituitary apoplexy (PA) is the paradigm of endocrine and neurosurgical emergency.
Objective
To evaluate the comorbidities, risk factors, clinical presentation, pituitary apoplexy score (PAS), and the outcomes of surgical vs conservative management of PA in Spain.
Methods
Spanish multicenter, observational study of 301 patients with acute PA. Statistical analyses compared risk factors, clinical presentation, and outcomes between surgical and conservative treatment groups, adjusting for potential confounders. The prevalence of cardiovascular risk factors in patients with PA was compared with the Spanish population and with patients with nonfunctioning pituitary adenomas.
Results
Median age was 59.3 years, 201 (66.8%) were men; nonfunctioning adenomas (77.9%) were the most common tumor type. The prevalence of diabetes (20.3% vs 13.9%, P < .01), hypertension (48.8% vs 33.4%, P < .01), and dyslipidemia (44.2% vs 23.3%, P < .01), exceeded the Spanish age-adjusted population prevalence. Overall, 209 (69.4%) underwent surgery and 92 (30.6%) received conservative treatment. Surgical patients had larger tumors (26.2 vs 21.0 mm, P < .01), more frequent chiasmal compression (77.2% vs 53.4%, P < .01), and higher values of PAS. In the follow-up, although there were no statistically significant differences in anterior pituitary hormonal deficits between treatments, permanent vasopressin deficiency was more frequent after surgery (14.8% vs 3.3%, P < .01).
Conclusions
There is a high burden of cardiovascular risk factors among patients with PA, suggesting that metabolic factors may play a potential role in the development of PA. This underscores the need for comprehensive management of these conditions in addition to treating the apoplexy itself in this population. Surgical management has a relevant place in PA approach mainly in patients with higher PAS. However, it leads a permanent vasopressin deficit more frequently than a conservative approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology & Nutrition Department, Hospital Universitario Vall de Hebrón, CIBERER U747 (ISCIII), ENDO-ERN, Universitat Autónoma de Bracelona, Barcelona, PC 08032, Spain.
- Neurosurgery Department, Hospital Universitario Vall de Hebrón, Departament de Cirurgia i Ciències Morfològiques, Universitat Autónoma de Barcelona, PC 08032, Spain.
- Department of Neurosurgery, Hospital Universitario La Paz, Madrid, PC 28046, Spain.
- Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, PC 28034, Spain.
- Endocrinology & Nutrition Service, La Fe University Hospital, Valencia, PC 46026, Spain.
- Department of Endocrinology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, PC 08907, Spain.
ORCID-Profile: Betina Biagetti, Marta Araujo-Castro, Cristina Lamas, Manel Puig-Domingo
Zitieren
APA
Biagetti, B., Cordero Asanza, E., Pérez-López, C., Araujo-Castro, M., Camara, R., Guerrero-Pérez, F., Vicente, A., Lamas, C., Serra, G., Echarri, A. I., Ollero, M. D., González Molero, I., Villar-Taibo, R., Moure Rodríguez, M. D., García-Feijoo, P., Berrocal, V. R., Sánchez Ramirez, M. N., Gutiéerrez Hurtado, A., Capristan-Díaz, V., …, & Puig-Domingo, M. (2025). Pituitary Apoplexy: Comorbidities, Management, and Outcomes—A Spanish Observational Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae649
Vancouver
Biagetti B, Cordero Asanza E, Pérez-López C, Araujo-Castro M, Camara R, Guerrero-Pérez F, et al. Pituitary Apoplexy: Comorbidities, Management, and Outcomes—A Spanish Observational Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae649
BibTeX
@article{Biagetti2025,
author = {Biagetti, Betina and Cordero Asanza, Esteban and Pérez-López, Carlos and Araujo-Castro, Marta and Camara, Rosa and Guerrero-Pérez, Fernando and Vicente, Almudena and Lamas, Cristina and Serra, Guillermo and Echarri, Ana Irigaray and Ollero, M Dolores and González Molero, Inmaculada and Villar-Taibo, Rocío and Moure Rodríguez, María Dolores and García-Feijoo, Pablo and Berrocal, Víctor Rodríguez and Sánchez Ramirez, María Noelia and Gutiéerrez Hurtado, Alba and Capristan-Díaz, Vanessa and Simó-Servat, Andreu and Gallach, Marta and Safont Perez, Eva and González Rosa, Victoria and Civantos, Soralla and Asensio-Wandosell, Diego and Martinez-Saez, Elena and Menéndez Torre, Edelmiro and Aulinas, Anna and Iglesias, Pedro and Diez, Juan J and Bernabéu, Ignacio and Álvarez-Escolá, Cristina and Puig-Domingo, Manel},
title = {Pituitary Apoplexy: Comorbidities, Management, and Outcomes—A Spanish Observational Multicenter Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae649}
}
EUVIMED